Complete Up To Date Information about Di-Trim Tablets.
NADA Number: 115-578 | |
| Proprietary Name |
Di-Trim® Tablets |
|---|---|
| Sponsor |
Fort Dodge Animal Health, Division of Wyeth |
| Sponsor Address |
800 Fifth Street NW Fort Dodge, IA 50501 USA |
| Ingredients |
Trimethoprim Sulfadiazine |
| Species |
Dog, no use class stated or implied |
| Routes of Administration |
Per Os |
| Dose Form |
Tablet |
| Drug Form |
Tablet |
| Dispensing Status |
RX |
|
Dosage Amount, Indications & Limitations |
520.2610 Trimethoprim and sulfadiazine tablets. Specifications: Each tablet contains 30 milligrams (5 milligrams of trimethoprim and 25 milligrams of sulfadiazine), 120 milligrams (20 milligrams of trimethoprim and 100 milligrams of sulfadiazine), 480 milligrams (80 milligrams of trimethoprim and 400 milligrams of sulfadiazine) or 960 milligrams (160 milligrams of trimethoprim 800 milligrams). Conditions of use: Dogs Amount: The drug is given orally at 30 milligrams per kilogram of body weight per day (14 milligrams per pound per day), or as follows: 30 milligram tablets 2.2 pounds body weight- 1 tablet 4.4 pounds body weight- 2 tablets 6.6 pounds body weight- 3 tablets 8.8 pounds body weight- 4 tablets 120 milligram tablets Up to 9 pounds body weight- 1 tablet 10 to 19 pounds body weight- 2 tablets 20 to 29 pounds body weight- 3 tablets 30 to 40 pounds body weight- 4 tablets 480 milligram tablets 30 to 40 pounds body weight- 1 tablet 40 to 60 pounds body weight- 1 1/2 60 to 80 pounds body weight- 2 tablets 80 to 110 pounds body weight- 3 tablets Over 110 pounds body weight- 4 tablets Indications: The drug is used in dogs where systemic antibacterial action against sensitive organisms is required, either alone or as an adjunct to surgery or debridement with associated infection. The drug is indicated where control of bacterial infection is required during the treatment of acute urinary tract infections, acute bacterial complications of distemper, acute respiratory tract infections, acute alimentary tract infections, wound infections, and abscesses. Limitations: The drug is given once daily. Alternatively, especially in severe infections, the initial dose may be followed by one-half the recommended daily dose every 12 hours. If no improvement is seen in 3 days, discontinue therapy and reevaluate diagnosis. Administer for 2 to 3 days after symptoms have subsided. Do not treat for more than 14 consecutive days. During long term treatment, periodic platelet counts and white and red blood cell counts are recommended. The drug should not be used in patients showing marked liver parenchymal damage or blood dyscrasia, nor in those with a history of sulfonamide sensitivity. Federal law restricts this drug to use by or on the order of a licensed veterinarian. |